Continuous stellate ganglion block for neurovascular headache and associated anxiety and depression
World Journal of Psychiatry · 19.07.2026 · 16 (7)
DOI: 10.5498/wjp.117484 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Psychiatry, online erschienen am 19.07.2026. Verfasst von Ye-Ming Wang und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND Neurovascular headache is a prevalent chronic pain syndrome (10%-15%) worldwide. 50%-80% of patients have comorbid anxiety or depression which triggers and perpetuates a pain-emotion vicious cycle with limited success in treatment. The sympathatic modulatory role of the stellate ganglion block (SGB) may produce pain relief and psychological symptom improvement, but few studies systematically evaluate dual effects and prognosis predictive factors for continuous SGB. This study aims to evaluate the 3-month efficacy of continuous SGB on pain and psychological symptoms, investigate the relationship between pain/emotion and provide predictors for treatment effects in order to optimize further clinical strategies. AIM To determine the effectiveness of ongoing SGB in improving pain severity and associated with anxiety and depression states in neurovascular headache patients and to define prognostic factors influencing treatment outcomes. METHODS A retrospective study enrolled 126 patients with neurovascular headache who received continuous SGB treatment from January 2020 to June 2024. Under ultrasound guidance, catheters were placed on the longus colli muscle surface with continuous infusion of 0.2% lidocaine (1 mL/hour) for 5 consecutive days on the left stellate ganglion, followed by 5 consecutive days on the right stellate ganglion, for a total treatment duration of 10 days. Visual Analog Scale scores, headache frequency, Self-Rating Anxiety Scale (SAS) scores, Self-Rating Depression Scale (SDS) scores, and quality of life were assessed at baseline, 1 week, 1 month, and 3 months post-treatment. RESULTS All 126 patients completed the full treatment course (5 consecutive days on the left stellate ganglion followed by 5 consecutive days on the right stellate ganglion, totaling 10 days). Follow-up assessments were completed by 126 patients (100%) at 1 week, 122 patients (96.8%) at 1 month, and 116 patients (92.1%) at 3 months post-treatment. At 3 months post-treatment, Visual Analog Scale scores decreased 54.4% (from 6.8 ± 1.2 to 3.1 ± 1.6, P < 0.001), headache frequency reduced 54.5% (from 12.3 ± 4.5 times/month to 5.6 ± 3.1 times/month, P < 0.001), and episode duration shortened 55.2% (P < 0.001). SAS scores decreased 15.6% with anxiety incidence dropping from 48.4% to 25.4% (P < 0.001). SDS scores declined 14.5% with depression incidence decreasing from 57.9% to 35.7% (P < 0.001). Total effective rate reached 86.5%. Pain relief correlated positively with anxiety improvement (r = 0.687, P < 0.001) and depression improvement (r = 0.652, P < 0.001). Shorter disease duration, absence of medication overuse, and lower baseline anxiety were independent favorable prognostic factors. No serious complications occurred. CONCLUSION Further, the treatment of neurovascular headache patients with continuous SGB results in safe and effective relief of pain symptoms and reductions in anxiety and depression, with efficacy sustained for up to 3 months. The association of pain relief and improvement in psychology is important and mutually reinforcing. We recommend for early intervention and baseline psychological assessment.
Zitieren
APA
Wang, Y., Liu, X., Sun, X., Li, N., Yang, Z., & Feng, T. (2026). Continuous stellate ganglion block for neurovascular headache and associated anxiety and depression. World Journal of Psychiatry, 16(7). https://doi.org/10.5498/wjp.117484
Vancouver
Wang Y, Liu X, Sun X, Li N, Yang Z, Feng T. Continuous stellate ganglion block for neurovascular headache and associated anxiety and depression. World Journal of Psychiatry. 2026;16(7). doi:10.5498/wjp.117484
BibTeX
@article{Wang2026,
author = {Wang, Ye-Ming and Liu, Xuan and Sun, Xiao-Jia and Li, Ning and Yang, Zhan-Long and Feng, Teng-Chen},
title = {Continuous stellate ganglion block for neurovascular headache and associated anxiety and depression},
journal = {World Journal of Psychiatry},
year = {2026},
volume = {16},
number = {7},
doi = {10.5498/wjp.117484}
}
EUVIMED